✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Clinical Summary # Clinical Summary The potential rescheduling of cannabis from Schedule I to...
Federal marijuana reclassification could reshape medical research and cannabis industry
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustryAging Clinical Summary The potential federal reclassification of marijuana from Schedule I to a lower...
Justice Department, DEA ordered to reclassify state-licensed medical cannabis as less … – Maui Now
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchSafety Clinical Summary A federal court has ordered the Department of Justice and DEA to...
State of Texas: Marijuana reclassification could expand medical research – Yahoo
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchAging Why This Matters Texas marijuana reclassification could enable clinical researchers to conduct more rigorous...
Trump administration reclassifies cannabis in major shift that could expand scientific research – MSN
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Why This Matters Reclassification of cannabis to a lower Schedule could accelerate rigorous clinical...
State-licensed medical marijuana reclassified as lower-risk drug by President Trump’s administration
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisRegulationResearchFederal Law Why This MattersReclassification of cannabis to a lower schedule could significantly...
. @crescolabs CEO: Rescheduling Ushers in a New Era of Medical Cannabis Patient Care –
✦ New CED Clinical Relevance #74Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyResearchMedical CannabisRegulationClinical Trials Why This MattersRescheduling cannabis from Schedule I to Schedule III would...
What marijuana reclassification means for Illinois – Axios Chicago
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyResearchMedical CannabisRegulationClinical Practice Why This MattersCannabis reclassification from Schedule I to Schedule III would...
Trump administration’s medical marijuana reclassification underway – YouTube
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyResearchFederal RegulationClinical PracticeDrug Scheduling Why This MattersFederal reclassification of cannabis from Schedule I would...
Trump Reclassifies State-Licensed Medical Cannabis, but It’s Not Legal Just Yet – Healthline
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafety Why This Matters Reclassifying cannabis to Schedule III could accelerate clinical research by removing...